← Leaderboards
Mark E Sale
Nuventra, Inc.
$197,917
Attributed
$197,917
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $125K · FY2021–22$200K$150K$100K$50K$0
'21
'22
Funding mix
By agency
FDA$197,917 · 1
By mechanism
U01$197,917 · 1
Top collaborators
No co-investigators on record.
Grant awards (2)
Development of machine learning approaches to population pharmacokinetic model selection and evaluation of application to model-based bioequivalence analysis.$125,000
U01 · FY2022 · FD · contact PI
Development of machine learning approaches to population pharmacokinetic model selection and evaluation of application to model-based bioequivalence analysis.$72,917
U01 · FY2021 · FD · contact PI